CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project focuses on plant secondary metabolites, particularly terpenes, to develop new therapeutic drugs for cancer and neurological disorders. It utilizes genomic and metabolomic technologies to enhance the understanding of biosynthetic pathways and create a library of bioactive compounds.
Plant secondary metabolites are an important source of therapeutic drugs or drug leads.
The advent of genomic and metabolomic technologies has now made it possible to bring the field of plant natural products into the 21st century and replace serendipitous and haphazard finding by rational design and discovery.
This proposal is devoted to plant terpenes, the largest and most diverse group of plant natural products. TERPMED will focus on sesquiterpene lactones and phenolic diterpenes because of t…
UNIVERSITAT DE BARCELONA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Netherlands, Wageningen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Netherlands, Weesp
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
ARISTOTLE UNIVERSITY OF THESSALONIKI
Greece, THESSALONIKI
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
